Publication|Videos|August 8, 2024
Reducing Patient Dropout Rates and Accelerating Trial Completion
Author(s)PCM Trials
Jon Ernst (Vice President, In-Home Solutions, Decentralized Clinical Trials) discusses today's clinical trial landscape.
Jon Ernst talked with ACT about how PCM Trials are harmonizing various elements in the decentralized clinical trial process.
Learn More About:
- The benefits of home visits in decentralized clinical trials
- What to look for in a home visit vendor for a successful study
- How home visits and community research sites have been misunderstood
Related Content
Trending on Applied Clinical Trials Online
1
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
2
ACT Brief: Data Standardization Bottleneck in Real-Time Monitoring, US Biotech FIH Trial Regulatory Frustration, and FDA Approval of Zenbexus for Multiple Myeloma
3
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
4
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
5